LUNGevity
National lung cancer nonprofit offering a free HELPLine with lung cancer navigators, one-on-one peer mentors, virtual meetups, online communities and the HOPE Summit; a major funder of lung cancer research.
39 organizations · Showing 21–39
National lung cancer nonprofit offering a free HELPLine with lung cancer navigators, one-on-one peer mentors, virtual meetups, online communities and the HOPE Summit; a major funder of lung cancer research.
AI-assisted clinical trial matching. Massive Bio reviews your records against active trials and sends a report, usually within 24 to 48 hours, and says the service is free for patients and their doctors. It also powers the American Cancer Society ACS ACTS program.
Free global support and navigation group for people with MET-altered cancer, including MET exon 14 skipping and MET amplification, and their care partners.
Minuteman Therapeutics is an early-stage company developing personalized oncolytic viruses, viruses designed to infect and break down cancer cells, matched to the biology of an individual patient's tumor.
Natera's Signatera is a personalized blood test, built from your tumor, that looks for traces of tumor DNA to check for remaining cancer, track treatment and catch a recurrence earlier. Your doctor orders it.
The National Cancer Institute's free, confidential information service. Specialists answer questions by phone, live chat and email, including help understanding treatment, finding NCI-supported clinical trials and locating cancer centers.
Free AI tool, no signup, that explains your records in plain English, finds trials and prepares questions for appointments. Answers cite NCCN guidelines, and Cancer Commons scientists can review your case.
Free app for people with cancer, including non-small cell lung cancer, that shows NCCN-based treatment options, tracks symptoms and medications, summarizes records and matches you to clinical trials.
Tests treatment options on tumor cells to help explore drug combinations.
Ranata Therapeutics is an early-stage company that aims to build biologic therapies, antibodies or bispecifics, designed around the unique features of an individual patient's cancer cells.
Explores biomarker-targeted imaging and radioligand approaches.
Develops blood-based tracking of a cancer’s presence, amount and changes over time.
Holon-S1 uses AI to infer spatial gene-expression patterns from digitized pathology slides. Research only.
Patient-directed tumor tissue preservation. SpeciCare mails a kit, you sign a directive to own your tissue, and it stores live and fixed tissue with a pathologist report. Storage is listed at $69 a month (October 2026).
Tumor preservation service that stores tissue or ascites from surgery or biopsy in viable frozen, fixed frozen and paraffin formats, so the patient can direct it to future testing, research or personalized treatment.
Tempus runs genomic tests on tumor tissue, blood and saliva to help guide treatment, check for inherited risk and monitor for remaining cancer. Your doctor orders the test.
Global nonprofit patient group, founded by patients and families, for adults and children with NTRK gene fusion cancers of any type, including lung, thyroid, sarcoma, salivary gland and brain tumors.
Tests drugs on live tumor cells outside the body and returns a report to the ordering physician.
Deep tumor profiling across DNA, RNA and proteins, using existing fixed tissue.